Alcohol and Breast Cancer Risk Defined by Estrogen and Progesterone Receptor Status: A Case-Control Study

Silvia Deandrea; Renato Talamini; Roberto Foschi; Maurizio Montella; Luigino Dal Maso; Fabio Falcini; Carlo La Vecchia; Silvia Franceschi; Eva Negri

doi:10.1158/1055-9965.epi-08-0157

Article2022

A DESCRIPTIVE OBSERVATIONAL STUDY OF DIFFERENCE OF ESTROGEN & PROGESTERONE RECEPTOR STATUS BEFORE AND AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER

Amarjeet Singh, Neeraj Kumar, Nagendra Singh Bhadauria, Raj Govind Sharma, Amit Kumar Singh

Article2017

Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort

Renée T. Fortner, Danja Sarink, Helena Schöck, Theron Johnson, Anne Tjønneland, Anja Olsen, Kim Overvad, Aurélie Affret, Mathilde His, Marie‐Christine Boutron‐Ruault, Heiner Boeing, Antonia Trichopoulou, Androniki Naska, Philippos Orfanos, Domenico Palli, Sabina Sieri, Amalia Mattiello, Rosario Tumino, Fulvio Ricceri, H. Bas Bueno‐de‐Mesquita, Petra H. Peeters, Carla H. van Gils, Elisabete Weiderpass, Eiliv Lund, J. Ramón Quirós, Antonio Agudo, María‐José Sánchez, María-Dolores Chirlaque, Eva Ardanáz, Miren Dorronsoro, Tim Key, Kay‐Tee Khaw, Sabina Rinaldi, Laure Dossus, Marc J. Gunter, Melissa A. Merritt, Elio Riboli, Rudolf Kaaks

Preprint2023

Data from Postmenopausal Serum Sex Steroids and Risk of Hormone Receptor–Positive and -Negative Breast Cancer: a Nested Case–Control Study

Rebecca E. James, Annekatrin Lukanova, Laure Dossus, Susen Becker, Sabina Rinaldi, Anne Tjønneland, Anja Olsen, Kim Overvad, Sylvie Mesrine, Pierre Engel, Françoise Clavel-Chapelon, Jenny Chang‐Claude, Alina Vrieling, Heiner Boeing, Madlen Schütze, Antonia Trichopoulou, Παγώνα Λάγιου, Dimitrios Trichopoulos, Domenico Palli, Vittorio Krogh, Salvatore Panico, Rosario Tumino, Carlotta Sacerdote,

Preprint2023

Data from Postmenopausal Serum Sex Steroids and Risk of Hormone Receptor–Positive and -Negative Breast Cancer: a Nested Case–Control Study

Rebecca E. James, Annekatrin Lukanova, Laure Dossus, Susen Becker, Sabina Rinaldi, Anne Tjønneland, Anja Olsen, Kim Overvad, Sylvie Mesrine, Pierre Engel, Françoise Clavel-Chapelon, Jenny Chang‐Claude, Alina Vrieling, Heiner Boeing, Madlen Schütze, Antonia Trichopoulou, Παγώνα Λάγιου, Dimitrios Trichopoulos, Domenico Palli, Vittorio Krogh, Salvatore Panico, Rosario Tumino, Carlotta Sacerdote,

Article2020

Dual Targeting of CDK4/6 and BCL2 Pathways Augments Tumor Response in Estrogen Receptor–Positive Breast Cancer

James R. Whittle, François Vaillant, Elliot Surgenor, Antonia N. Policheni, Göknur Giner, Bianca D. Capaldo, Huei-Rong Chen, He K. Liu, Johanna F. Dekkers, Norman Sachs, Hans Clevers, Andrew Fellowes, Thomas Green, Hui-Ling Xu, Stephen B. Fox, Marco J. Herold, Gordon K. Smyth, Daniel H.D. Gray, Jane E. Visvader, Geoffrey J. Lindeman

Alcohol and Breast Cancer Risk Defined by Estrogen and Progesterone Receptor Status: A Case-Control Study

Abstract

Discussion(0)

Related publications

A DESCRIPTIVE OBSERVATIONAL STUDY OF DIFFERENCE OF ESTROGEN & PROGESTERONE RECEPTOR STATUS BEFORE AND AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER

Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort

Data from Postmenopausal Serum Sex Steroids and Risk of Hormone Receptor–Positive and -Negative Breast Cancer: a Nested Case–Control Study

Data from Postmenopausal Serum Sex Steroids and Risk of Hormone Receptor–Positive and -Negative Breast Cancer: a Nested Case–Control Study

Dual Targeting of CDK4/6 and BCL2 Pathways Augments Tumor Response in Estrogen Receptor–Positive Breast Cancer

Alcohol and Breast Cancer Risk Defined by Estrogen and Progesterone Receptor Status: A Case-Control Study

Abstract

Discussion(0)

Related publications

A DESCRIPTIVE OBSERVATIONAL STUDY OF DIFFERENCE OF ESTROGEN &amp; PROGESTERONE RECEPTOR STATUS BEFORE AND AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER

Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort

Data from Postmenopausal Serum Sex Steroids and Risk of Hormone Receptor–Positive and -Negative Breast Cancer: a Nested Case–Control Study

Data from Postmenopausal Serum Sex Steroids and Risk of Hormone Receptor–Positive and -Negative Breast Cancer: a Nested Case–Control Study

Dual Targeting of CDK4/6 and BCL2 Pathways Augments Tumor Response in Estrogen Receptor–Positive Breast Cancer

A DESCRIPTIVE OBSERVATIONAL STUDY OF DIFFERENCE OF ESTROGEN & PROGESTERONE RECEPTOR STATUS BEFORE AND AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER